VERSITI BLOOD HEALTH, INC.
TULSA, Wisconsin
Total Received
$151.7M
Total Awards
88
State
Wisconsin
Last Updated
Mar 20, 2026
Yearly Funding Trend
$117.7M24
$30.1M25
$4.0M26
Top 50 Awards to VERSITI BLOOD HEALTH, INC.
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 20, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_P01HL144457_075 ZIMMERMAN PROGRAM ON THE BIOLOGY OF VWD - PROJECT SUMMARY: OVERALL THIS PROGRAM PROJECT GRANT ON REMAINING CRITICAL ISSUES CONCERNING THE MOLECULAR AND BIOLOGIC CONTROL OF VON WIL… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2025 | $13,270,012 |
ASST_NON_P01HL151333_075 MOLECULAR AND CLINICAL GLYCOBIOLOGY OF THE BONE MARROW ENVIRONMENT - THE LIFE-LONG PRODUCTION OF BLOOD CELLS REQUIRES HEMATOPOIETIC DEVELOPMENTAL PROGRAMS GUIDED BY SYSTEMIC AND L… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2024 | $12,294,902 |
ASST_NON_R01HL089224_075 CARBOHYDRATE-MEDIATED PLATELET CLEARANCE - ABSTRACT MAINTENANCE OF NORMAL HEMATOPOIESIS DEPENDS ON DEVELOPMENTAL PROGRAMS FOR THE HEMATOPOIETIC STEM AND PROGENITOR CELL (HSPC). ST… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2024 | $8,814,944 |
ASST_NON_R01HL068835_075 CHARACTERIZATION OF AN ISOFORM SPECIFIC ANTICOAGULANT FUNCTION OF TFPI-ALPHA - ABSTRACT TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IS AN ANTICOAGULANT PROTEIN WITH ESSENTIAL ROLES IN… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2024 | $7,751,533 |
ASST_NON_R35HL139937_075 BASIC INVESTIGATION AND TRANSLATIONAL APPLICATIONS CONCERNING THE CELL AND MOLECULAR BIOLOGY OF BLOOD AND VASCULAR CELLS - STUDIES PROPOSED IN THIS APPLICATION ENCOMPASS AND EXTEN… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2024 | $6,886,650 |
CONT_AWD_HT942523C0095_9700_-NONE-_-NONE- PROPOSAL JOINT WARFIGHTER 20021 - CONTRACT | Department of Defense Defense Health Agency | — | MILWAUKEE, WI-04 | 2024 | $6,485,297 |
ASST_NON_R01HL131836_075 STRUCTURAL TRANSITION OF CELLULAR INTEGRINS AND APPLICATIONS THEREOF - SUMMARY - INTEGRINS ARE Α/Β HETERODIMERIC CELL SURFACE RECEPTORS, WHICH, VIA THEIR ABILITY TO BIND LIGANDS T… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2025 | $5,469,484 |
ASST_NON_P01HL167668_075 MOLECULAR MECHANISMS OF IMMUNE THROMBOCYTOPENIA IN TRANSFUSION MEDICINE - OVERALL COMPONENT – PROJECT SUMMARY/ABSTRACT THIS REVISED APPLICATION FOR A PROGRAM PROJECT SEEKS SUPPOR… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2024 | $5,130,743 |
ASST_NON_K12HL141954_075 GLYCANS IN BLOOD HOMEOSTASIS AND DISEASE - PROJECT SUMMARY IN RESPONSE TO THE URGENT NEED TO “TRANSFORM AND DEMOCRATIZE GLYCOSCIENCES FROM A SUPER-SPECIALIZED RESEARCH DOMAIN INTO… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2025 | $4,866,000 |
ASST_NON_R01HL130724_075 B CELL RESPONSES IN HEPARIN-INDUCED THROMBOCYTOPENIA - ABSTRACT HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) IS THE MOST COMMON DRUG-INDUCED IMMUNE THROMBOCYTOPENIA AND CAN LEAD TO CATA… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2024 | $4,762,980 |
ASST_NON_R01AI160244_075 DEVELOPMENT OF A B CELL THERAPEUTIC - AUTOIMMUNITY OCCURS DUE TO A BREAKDOWN IN IMMUNOLOGICAL TOLERANCE, LEADING TO UNCONTROLLED ADAPTIVE IMMUNE RESPONSES AGAINST SELF-TISSUES. TH… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | MILWAUKEE, WI-04 | 2024 | $3,391,258 |
CONT_AWD_75N92021F00001_7529_75N92019D00035_7529 REDS-IV-P DOMESTIC HUB PHASE 2 | Department of Health and Human Services National Institutes of Health | — | MILWAUKEE, WI-04 | 2024 | $3,162,100 |
ASST_NON_R01AI148403_075 PHENOTYPIC, FUNCTIONAL AND TRANSCRIPTIONAL HETEROGENEITY IN T CELL EXHAUSTION - ABSTRACT T CELL EXHAUSTION IS A DIFFERENTIATION STATE THAT IS MARKED BY THE LOSS OF EFFECTOR FUNCTI… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | IL-90 | 2024 | $3,080,250 |
ASST_NON_R01HL157893_075 ENDOTHELIAL RAP1 IN THE CONTROL OF HEART FUNCTION - CARDIOVASCULAR DISEASE (CVD) IS A GLOBAL PANDEMIC WITH OVER 26 MILLION PEOPLE AFFECTED WORLDWIDE. CRITICAL FOR REGULATION OF HE… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2024 | $2,940,444 |
ASST_NON_R01HL148120_075 MOLECULAR BASIS OF THE HUMORAL IMMUNE RESPONSE IN HEPARIN-INDUCED THROMBOCYTOPENIA - ABSTRACT HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) IS A SEVERE IMMUNE REACTION CAUSED BY HEPARIN… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2024 | $2,932,503 |
ASST_NON_R01CA254354_075 TARGETING THE METABOLIC REGULATOR SIRT5 IN ACUTE MYELOID LEUKEMIA - PROJECT SUMMARY TARGETING THE METABOLIC REGULATOR SIRT5 IN ACUTE MYELOID LEUKEMIA. AML IS AN AGGRESSIVE HEMATOL… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | MILWAUKEE, WI-04 | 2024 | $2,891,219 |
ASST_NON_R37CA229751_075 THE HISTONE DEMETHYLASE JMJD1C IN HUMAN ACUTE MYELOID LEUKEMIA - PROJECT SUMMARY CURRENT THERAPY FOR ACUTE MYELOID LEUKEMIA (AML) IS INADEQUATE. DESPITE NEWLY AVAILABLE THERAPEUTI… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | LA JOLLA, CA-50 | 2024 | $2,830,378 |
ASST_NON_R01HL149364_075 TFPI, PROTEIN S, AND PLASMA FIXA IN HORMONE-INDUCED HYPERCOAGULABILITY - VENOUS THROMBOEMBOLISM (VTE) IN WOMEN TAKING ORAL CONTRACEPTIVES (OC) IS A PROBLEM OF BROAD CLINICAL SIGNI… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2024 | $2,796,684 |
ASST_NON_R01HL161127_075 B-CELL RESPONSE AND THROMBOTIC COMPLICATIONS IN COVID-19 - ABSTRACT COVID-19 SEVERITY/LETHALITY IS ASSOCIATED WITH A DYSFUNCTIONAL INFLAMMATORY IMMUNE RESPONSE AND A HYPER- ENGAGE… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2024 | $2,626,288 |
ASST_NON_R01HL139847_075 MOLECULAR INTERACTIONS OF FVIII AND VWF - PROJECT SUMMARY HEMOPHILIA A (FACTOR VIII DEFICIENCY) AND VON WILLEBRAND DISEASE (VWF DEFICIENCY) ARE WELL RECOGNIZED SEVERE AND/OR COMMO… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2024 | $2,345,148 |
ASST_NON_R01HL166345_075 CD39-CARRYING EXTRACELLULAR VESICLES REGULATE PULMONARY THROMBOSIS IN SICKLE CELL DISEASE - PROJECT SUMMARY SICKLE CELL DISEASE (SCD) IS THE MOST COMMON HEMOLYTIC DISORDER AFFECTI… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | PA-90 | 2024 | $2,342,450 |
ASST_NON_R01HL166382_075 UNDERSTANDING AND CONTROLLING THE CONTRIBUTION OF FIBRINOLYSIS TO BLEEDING USING A LONG-ACTING ANTIFIBRINOLYTIC RNA THERAPY - SUMMARY BACKGROUND: THE BALANCE BETWEEN CLOT FORMATIO… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2024 | $2,182,730 |
ASST_NON_R35GM142926_075 INVESTIGATING THE REGULATION AND SUBSTRATE PROCESSING OF ADAMTS13 AND ADAMTS7 METALLOPROTEASES - PROJECT SUMMARY THIS MIRA PROPOSAL AIMS TO UNCOVER THE REGULATORY MECHANISMS AND S… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | OK-90 | 2024 | $2,024,049 |
ASST_NON_W81XWH2110969_097 THIS MODIFICATION:1.EXTENDS THE POP BY 12 MONTHS. TECHNICAL AND FINANCIAL REPORTING SHALL CONTINUE IN ACCORDANCE WITH THE AWARD TERMS AND CONDITIONS.2.UPDATES DIVISION I ITEMS A.7… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | MILWAUKEE, WI-04 | 2024 | $2,000,000 |
ASST_NON_HT94252410943_097 CONTROLLING THROMBOEMBOLISM AFTER POLYTRAUMA WITH AN RNA THERAPY AGAINST EXCESS FIBRINOGEN INCORPORATE REVISED STATEMENT OF WORK | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | MILWAUKEE, WI-04 | 2024 | $1,993,215 |
ASST_NON_R01CA204231_075 COHESIN MUTATIONS IN ACUTE MYELOGENOUS LEUKEMIA - ABSTRACT: ACUTE MYELOGENOUS LEUKEMIA (AML) IS A BONE MARROW-DERIVED MALIGNANCY AND REMAINS A CLINICAL CHALLENGE, WITH LONG-TERM S… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | MILWAUKEE, WI-04 | 2024 | $1,911,720 |
ASST_NON_R01CA257602_075 STRATEGIES TO TARGET BCR-ABL1 COMPOUND MUTANTS IN CML AND PH+ ALL - ABSTRACT: PHILADELPHIA CHROMOSOME-POSITIVE (PH+) LEUKEMIA IS CAUSED BY BCR-ABL1, A CONSTITUTIVELY ACTIVE FUSION… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | MILWAUKEE, WI-04 | 2024 | $1,824,626 |
ASST_NON_R01HL160861_075 KINDLIN-3 SIGNALING IN NEUTROPHILS - PROJECT SUMMARY/ABSTRACT INFLAMMATION PLAYS A PIVOTAL ROLE IN THE RAPID REMOVAL OF HARMFUL STIMULI, EITHER STERILE OR INFECTIOUS; HOWEVER, UNC… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2024 | $1,801,567 |
ASST_NON_R01HL157309_075 KINDLIN-3 SIGNALING IN PLATELETS - INTEGRIN ΑIIBΒ3 ACTIVATION IN PLATELETS IS AN IMPORTANT STEP ON THE ROAD TO FIBRINOGEN BINDING, PLATELET AGGREGATION, AND PRIMARY HEMOSTASIS. OV… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2024 | $1,742,425 |
CONT_AWD_75N92019F00074_7529_75N92019D00035_7529 COR CHANGE | Department of Health and Human Services National Institutes of Health | — | MILWAUKEE, WI-04 | 2024 | $1,733,965 |
ASST_NON_R01HL136430_075 VWF - MECHANISMS OF REGULATION - PROJECT SUMMARY THE REGULATION OF PLASMA VON WILLEBRAND FACTOR (VWF) LEVEL IS CRITICAL FOR HEMOSTASIS, AS VWF BOTH MEDIATES PLATELET ADHESION AT S… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2024 | $1,683,273 |
CONT_AWD_75N92024F00001_7529_75N92019D00035_7529 REDS-IV-P DOMESTIC HUBS | Department of Health and Human Services National Institutes of Health | — | MILWAUKEE, WI-04 | 2024 | $1,656,613 |
ASST_NON_R01CA268496_075 THE FUNCTION OF MS4A3 IN NORMAL AND MALIGNANT HEMATOPOIESIS - CHRONIC MYELOID LEUKEMIA (CML) IS CAUSED BY BCR-ABL1, A CONSTITUTIVELY ACTIVE TYROSINE KINASE GENERATED FROM THE PHIL… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | MILWAUKEE, WI-04 | 2024 | $1,532,077 |
ASST_NON_R01HL175474_075 NON-CONVENTIONAL SIGNALING BY Α5 INTEGRIN IN BLOOD AND ENDOTHELIAL CELLS - SUMMARY – INTEGRINS INTERACT WITH THEIR LIGANDS TO INDUCE INTRACELLULAR SIGNALS THAT MEDIATE CELLULAR AC… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2024 | $1,437,708 |
ASST_NON_R01GM137143_075 STRUCTURAL MECHANISMS UNDERLYING THE ACTIVITY REGULATION OF THE RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASE, CD148/PTPRJ - SUMMARY - PROTEIN TYROSINE PHOSPHORYLATION AND DEPHOSPHOR… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | MILWAUKEE, WI-04 | 2025 | $1,410,500 |
ASST_NON_R01EY036588_075 ENDOTHELIAL RAP1 RESTRICTS INFLAMMATION IN THE RETINA - PROJECT SUMMARY ENDOTHELIAL-LEUKOCYTE INTERACTIONS ARE PIVOTAL IN DIABETIC RETINOPATHY (DR), A MAJOR CAUSE OF GLOBAL VISIO… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MILWAUKEE, WI-04 | 2024 | $1,173,571 |
ASST_NON_R35HL183465_075 DECODING KINDLIN-3 SIGNALING IN PLATELETS AND NEUTROPHILS - PROJECT SUMMARY THE STUDIES PROPOSED IN THIS APPLICATION REFLECT THE PRINCIPAL INVESTIGATOR’S LONG-STANDING COMMITMENT… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2026 | $1,069,072 |
ASST_NON_R01HL169144_075 INTERROGATING CLINICALLY RELEVANT ATTRIBUTES OF MATERNAL ALLOIMMUNITY IN FETAL/NEONATAL ALLOIMMUNE THROMBOCYTOPENIA - ABSTRACT IMMUNE RESPONSES TO PLATELET ALLOANTIGENS CAUSE PATH… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2024 | $935,260 |
ASST_NON_K08HL146941_075 THE ROLE IN INFLAMMATION IN PLATELET ACTIVATION AND THROMBOSIS - PROJECT SUMMARY MY PRIMARY HYPOTHESIS IS THAT GAS6/MERTK SIGNALING IS UPREGULATED IN THE SETTING OF INFLAMMATION,… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MILWAUKEE, WI-04 | 2024 | $810,215 |
CONT_AWD_36C25225N0018_3600_36C25221D0072_3600 BLOOD AND BLOOD PRODUCTS | Department of Veterans Affairs Department of Veterans Affairs | — | MILWAUKEE, WI-04 | 2025 | $787,975 |
CONT_AWD_36C25226N0039_3600_36C25221D0072_3600 BLOOD AND BLOOD PRODUCTS | Department of Veterans Affairs Department of Veterans Affairs | — | MILWAUKEE, WI-04 | 2026 | $750,000 |
ASST_NON_K01DK125617_075 MOLECULAR MECHANISM OF SICKLE CELL HEPATIC CRISIS - PROJECT SUMMARY/ABSTRACT THE GOAL OF THIS PROPOSAL IS TO EXTEND MY TRAINING AS AN INDEPENDENT SCIENTIST IN THE FIELD OF HEPATIC… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | PA-90 | 2024 | $736,235 |
CONT_AWD_HHSN26800003_7529_HHSN268201100003I_7529 DBDR REDS-III DOMESTIC SITE PHASE 3 | Department of Health and Human Services National Institutes of Health | — | MILWAUKEE, WI-04 | 2024 | $720,000 |
CONT_AWD_36C25223N0055_3600_36C25221D0073_3600 BLOOD AND BLOOD PRODUCTS FOR VHA VISN 12 | Department of Veterans Affairs Department of Veterans Affairs | — | MILWAUKEE, WI-04 | 2024 | $696,899 |
ASST_NON_S10OD038306_075 HIGH PARAMETER FLUORESCENCE ACTIVATED CELL SORTER - PROJECT SUMMARY/ABSTRACT THE VERSITI BLOOD RESEARCH INSTITUTE (VBRI) IS AN ACADEMIC HEMATOLOGY RESEARCH CENTER LOCATED IN MILWA… | Department of Health and Human Services National Institutes of Health | 93.351 RESEARCH INFRASTRUCTURE PROGRAMS | MILWAUKEE, WI-04 | 2025 | $679,925 |
CONT_AWD_36C25226N0069_3600_36C25221D0073_3600 BLOOD AND BLOOD PRODUCTS FOR VHA VISN 12 | Department of Veterans Affairs Department of Veterans Affairs | — | MILWAUKEE, WI-04 | 2026 | $675,000 |
CONT_AWD_36C25225N0019_3600_36C25221D0073_3600 BLOOD AND BLOOD PRODUCTS FOR VHA VISN 12 | Department of Veterans Affairs Department of Veterans Affairs | — | MILWAUKEE, WI-04 | 2025 | $642,636 |
CONT_AWD_36C25224N0025_3600_36C25221D0073_3600 BLOOD AND BLOOD PRODUCTS FOR VHA VISN 12 | Department of Veterans Affairs Department of Veterans Affairs | — | MILWAUKEE, WI-04 | 2024 | $618,740 |
CONT_AWD_36C25224N0023_3600_36C25221D0073_3600 BLOOD AND BLOOD PRODUCTS FOR VHA VISN 12 | Department of Veterans Affairs Department of Veterans Affairs | — | MILWAUKEE, WI-04 | 2024 | $611,722 |
ASST_NON_R21CA256128_075 A BIOLUMINESCENT ASSAY FOR DIRECT MEASUREMENT OF SIRTUIN ACTIVITY IN CANCER CELLS - A BIOLUMINESCENT ASSAY FOR DIRECT MEASUREMENT OF SIRTUIN ACTIVITY IN CANCER CELLS SIRTUINS ARE… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | WI-90 | 2024 | $604,635 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Industries
View All→123456789
BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING$10.2M
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)$6.6M
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)$6.5M
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)$720K
BLOOD AND ORGAN BANKS$30K
SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING$16K
TESTING LABORATORIES AND SERVICES$11K
MEDICAL LABORATORIES$9K
ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING$6K
Federal Programs (CFDA)
View All→12345678910
93.837 — CARDIOVASCULAR DISEASES RESEARCH$98.0M
93.396 — CANCER BIOLOGY RESEARCH$9.8M
12.420 — MILITARY MEDICAL RESEARCH AND DEVELOPMENT$4.0M
93.859 — BIOMEDICAL RESEARCH AND RESEARCH TRAINING$3.4M
93.310 — TRANS-NIH RESEARCH SUPPORT$3.4M
93.855 — ALLERGY AND INFECTIOUS DISEASES RESEARCH$3.3M
93.395 — CANCER TREATMENT RESEARCH$2.4M
93.867 — VISION RESEARCH$1.2M
93.847 — DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$1.1M
93.351 — RESEARCH INFRASTRUCTURE PROGRAMS$680K
Source: USAspending.gov · All Recipients · Wisconsin